ArticleViruses2024

Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications.

Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.